News
Five years from now, when patients walk into a doctor’s office presenting symptoms of almost any condition you can envision — whether migraine, multiple sclerosis, or obesity — their ...
Kal Patel, M.D., is CEO and cofounder of BrightInsight. He has over 20 years of experience in pharma, medtech and regulated digital health. When it comes to digital health, the pharmaceutical ...
Pharma and healthcare digital ad spending is on the rise. But it’s a slow go. While the category is poised to reach $2.84 billion this year, it’s still the slowest grower out of 10 categories ...
The investigation into health data giant IQVIA’s ad tech deal focuses on harm to rivals and increased costs for drugmakers. The Federal Trade Commission is currently investigating a merger in an ...
More pharma and healthcare ads are coming to your digital news feed, but don’t worry; you'll still get plenty to satisfy your appetite for car, clothing and consumer ads. That rising tide ...
Kal Patel, M.D., is CEO and cofounder of BrightInsight. He has over 20 years of experience in pharma, medtech and regulated digital health. The days of “growth at all cost” are over.
Digital therapeutics developers and pharma companies would seem to be natural partners. Many digital therapeutics companies are hoping to find their way to the patient populations that pharma ...
To stay relevant, pharma marketers must move from a “broadcast” model to an “engagement” model, prioritizing education, storytelling, and personalized digital experiences. For example ...
The track record of Big Pharma collaborations with digital health startups has been at best nothing to write home about. At worst, an abject failure. “They are almost often speaking across ...
The global digital twin technology in pharmaceutical manufacturing market is estimated at US$307.4 million in 2024 and is projected to grow at a CAGR of 31.3% during the forecast period 2024-2034.
An end-to-end digital supply chain network is a fully integrated ecosystem connecting every component of the supply chain, from raw-material suppliers to patients. But in achieving this goal, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results